This Week on Capitol Hill: Patent Eligibility Hearings, Protecting Taxpayer-Funded Research, and Licensing Nuclear Technologies IPWatchdog.com
Those who oppose reforms to Section 101 are briefing staffers on the Hill today in an attempt to conflate the patent eligibility and drug pricing/ gene patenting …